Hormone therapy use and duration with postoperative radiotherapy for recurrent prostate cancer: an individual patient data meta-analysis

Journal:
The Lancet
Published:
Affiliations:
26
Authors:
33
Institutions Authors Share
University of California, Los Angeles (UCLA), United States of America (USA)
10.500000
10.500000
0.32
UH Seidman Cancer Center, CWRU, United States of America (USA)
8.000000
0.24
Centre Léon Bérard (CLB), France
1.500000
0.05
NRG Oncology Statistical and Data Management Center (SDMC), United States of America (USA)
1.500000
0.05
MRC Clinical Trials Unit (CTU), United Kingdom (UK)
1.000000
0.03
Bergonié Cancer Institute, France
1.000000
0.03
UNICANCER Group, France
1.000000
0.03
University of Washington (UW), United States of America (USA)
1.000000
0.03
Massachusetts General Hospital (MGH), United States of America (USA)
1.000000
0.03
Sylvester Comprehensive Cancer Center (Sylvester), UM, United States of America (USA)
1.000000
0.03
Cedars-Sinai Medical Center (Cedars-Sinai), United States of America (USA)
1.000000
0.03
The Royal Marsden NHS Foundation Trust, United Kingdom (UK)
0.500000
0.02
The Institute of Cancer Research (ICR), United Kingdom (UK)
0.500000
0.02
VA Greater Los Angeles Healthcare System, United States of America (USA)
0.500000
0.02
The University of Texas MD Anderson Cancer Center, United States of America (USA)
0.500000
0.02
American University of Beirut (AUB), Lebanon
0.500000
0.02
The University of Chicago (UChicago), United States of America (USA)
0.500000
0.02
Brigham and Women's Hospital (BWH), United States of America (USA)
0.500000
0.02
Dana-Farber Cancer Institute (DFCI), United States of America (USA)
0.500000
0.02
Curie Institute, France
0.500000
0.02